| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.04 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.04 |